Can vendors use the word “telepathology”?

 

Can vendors use the word "telepathology" in marketing materials?  Few do out of concern due to lack of FDA clearance for the scanning device.  Companies based overseas are particularly reluctant and dare say the term.  Even some of the newer vendors to the space are careful to point out that their devices are for "research purposes only" and disclaimers to the effect that the devices have not been cleared by the FDA for primary interpretation are nearly universal among vendors.  

So, manufacturers do not make a claim that their device can be used for primary H&E reads.

Enter AccelPath which I mentioned a couple of weeks ago in a post.  Since that post, courtesy of Laboratory Economics (subscription required) they recently reported that:

"AccelPath LLC (Westwood, MA) has partnered with the in-office lab consulting firm Triangle Biomedical Sciences (TBS-Durham, NC) and begun marketing digital pathology services to urology, gastroenterology and dermatology groups. Under the partnership, TBS will help specialty groups build in-office labs and AccelPath will install digital slide scanners. Digitized slide images will be sent electronically to AccelPath, which has contracted with the Pathology Department at the Lahey Clinic (Burlington, MA) for professional interpretations."

 On AccelPath's website they mention specifically "primary interpretations" as one of the many uses with these added value propositions:

  • Eliminate the cost, delays and logistics of shipping slides and blocks
  • Eliminate the need to recruit, hire and retain pathologists
  • Enjoy full access to AccelPath's prestigious team of U.S. based pathologists
  • Receive fastest slide-to-report service
  • Obtain 24/7 access to digital archives of all reports, requisitions and images
  • Maintain control by keeping all slides on site at all times
  • Implement our program easily with support from trained professionals

All of this is both encouraging and a real threat with continued commoditization of pathology services.

Laboratory Economics notes that the transaction has created the first publicly-traded company focused on two key trends in anatomic pathology (i.e., digital pathology and in-office histology labs).

This means clinicians in-source histology for the technical component and out-source the professional component in lieu of an in-office pathologist or local pathology group.

Apparently, they are comfortable with primary reads although I am not clear what scanner(s) are being used and how they have addressed the issue.  Presumably they have validated the technology internally and are confident in their ability to offer fast, accurate diagnoses. 

?The encouraging part is that this marriage between in-office labs and digital pathology with a validated system allows for other groups to replicate the model whether it is a local GI group who is going to bring histology "in house" to referring work to other pathologists from primary laboratories for primary reads.  Unmanned pathology shops with 24/7 MD support. 

?This may provide a completely legitimate way for pathologists to try to "get back" work that has been "lost" to in-office labs with medical director oversight of the laboratory and a TC/PC arrangement where the parties involved get paid for what they are doing rather than having employed pathologists who may not see the full PC for work that he/she has done.

?Is this a threat or opportunity for pathology?

?About AccelPath

AccelPath was formed in October 2008 by Shekhar Wadekar, PhD, chief executive, and H. Lance Evans, MD, head of medical affairs. Wadekar has a PhD in engineering from the University of Delaware and an MBA from New York University. Evans is a board-certified pathologist and practiced hematopathology at Impath (now part of LabCorp/Genzyme Genetics).

AccelPath was recently acquired by Technest Holdings Inc. (Bethesda, MD). Technest is a penny-stock company that trades on the OTC Bulletin Board at a current price of about 8 cents per share (as of March 15). Technest issued 86 million shares valued at roughly $6.5 million to purchase AccelPath. As a result of this reverse-buyout transaction, AccelPath members now own approximately 72.5% of Technest and Wadekar has become chief executive.

Finnish researchers develop giant multi-user microscope

Finnish researchers have created an innovative new microscope that responds to hand and finger gestures on a giant touch screen. Looks like the images are off of a Mirax scanner.

 

More information on MutliTouch (English pdf).

The 'multitouch microscope' is the fruit of collaboration between researchers from the Institute for Molecular Medicine Finland (FIMM), and the Finnish company Multitouch Ltd, who specialise in professional multitouch displays and software platforms that support multi-user environments.

The microscope works like a giant interactive touch screen and can be operated by multiple users, bringing new opportunities to teaching and research.

'The giant size, minimum 46 inch screen looks somewhat like an iPad on steroids,' says researcher Johan Lundin, one of the developers of the microscope. 'The sample viewing experience is like a combination of Google Maps and the user interface from the movie Minority Report.'

The resulting user experience is an entirely new way of performing microscopy. By simply touching a giant screen, in the form of a table or even a wall-mounted screen, the user can navigate and zoom within a microscope sample in the same way as with a conventional microscope. However, using the touch control it is possible to move from the natural size of the sample to a 1,000-fold magnification, at which cells and even subcellular details can be seen.

The microscope works by digitising biological samples using a microscopy scanner and storing them on an image server. Samples displayed on the screen are then continuously read from the server over the Internet and the size of a single sample can be up to 200 gigabytes (GB).

It is hoped that the accessibility of the format will encourage more students to engage with microscopy. The developers think that the method will revolutionise microscopy teaching as a group of students can stand around the display together with the teacher and examine the same sample. The multitouch function of the microscope means that a whole class of students can work on one biological sample at the same time, improving student engagement.

'The multitouch microscope brings a new dimension into interactive teaching and the learning curve is practically zero when compared to conventional microscopy which can be quite challenging for students,' explains Lundin.

Lundin also points out that the microscope will be invaluable for scientific meetings or any 'situation where a group of users need to simultaneously view a microscopy sample, for example when a consensus needs to be reached concerning a new disease entity or a rare case.'

The multitouch microscope builds on the success of another Finnish innovation - web-based virtual microscopy or the 'WebMicroscope', which was developed a few years ago by researchers from the University of Helsinki and the University of Tampere. This has been well received among students and is used at more than 10 European universities and in many countries for laboratory quality assurance.

In virtual microscopy a digital copy of a sample on a glass slide is created. A virtual slide can consist of up to 50,000 separate digital images aligned into a mosaic representing the whole sample at high magnification. The image mosaic can be viewed over the Internet using a common web browser and the user can select any area or magnification as in conventional microscopy.

The FIMM is an international research institute focusing on building a bridge from discovery to medical applications. FIMM investigates molecular mechanisms of disease using genomics and medical systems biology in order to promote human health. FIMM is a multidisciplinary institute combining high-quality science with unique patient materials, and state-of-the-art technologies.

For more information, please visit:

Institute for Molecular Medicine Finland (FIMM):
http://www.fimm.fi

To view a presentation on the multitouch microscope click here:
http://www.youtube.com/user/multitouchfi?feature=mhum#p/u/12/ihaM3DvyUHE

Category: Miscellaneous
Data Source Provider: Institute for Molecular Medicine Finland (FIMM)
Document Reference: Based on information provided by the Institute for Molecular Medicine Finland (FIMM)
Subject Index: Education, Training; Innovation, Technology Transfer; Life Sciences; Medicine, Health; Scientific Research

Anatomical Obscura Day Events, 2011


As many of you already know, my upcoming exhibition--The Great Coney Island Spectacularium--will be launching with an Obscura Day event on Saturday April 9th (more on that here.) If you are not in New York for Obscura Day, or are in the mood for more anatomical fare, I have just been alerted to a bunch of anatomical-themed events that might be up your alley. All events take place on Saturday, April 9th.

Details follow:

  • At the Dittrick Museum where Jim, the Dittrick's Chief Curator, will present a selection of amazing and rare anatomy atlases and surgical works, and Jenny, the Registrar and Archivist, will share a sampling of strange and wonderful objects from the Dittrick artifact collections, with special emphasis upon the history of contraception, a premier collection at the Dittrick. (http://obscuraday-dittrick.eventbrite.com/)
  • At the International Museum of Surgical Science, in Chicago the Museum’s curator will present 3D stereoscopic photos, chromolithographs, and a magic lantern show depicting skin diseases in gorgeous, gruesome detail. Visitors can take a look at what lies beneath the surface of the skin in a special exhibition of actual human bodies. (http://obscuraday-imss.eventbrite.com/)
  • In Florence, Itlay take an expert tour of La Specola Anatomical Collection. Art and social-historian Sheila Barker, who researches science and medicine in Renaissance Florence, will lead the visit of some of the most spectacular and beautiful anatomical artwork in the world. (http://obscuraday-laspecola.eventbrite.com/)
  • In Sydney, Australia go to the Museum of Human Disease, where on Obscura Day you can ask questions of academics and researchers from the University, and participate in discussions and workshops and hear the stories of patients, medical professionals, and loved ones of those with disease." (http://obscuraday-museumhumandisease.eventbrite.com/)

To find out more about these events, and to purchase tickets, click the link following each description.

Image: "Anatomical Venus" Wax wodel with human hair and pearls in rosewood and Venetian glass case, "La Specola" (Museo di Storia Naturale), Florence, Italy " Probably modeled by Clemente Susini (around 1790); From The Secret Museum exhibition.

Naming the Animals Exhibition Opening, Curious Matter, Jersey City, Sunday April 3


I have a photograph--sneak preview above--included in the upcoming Naming the Animals exhibition at Curious Matter gallery in Jersey City, New Jersey. The opening--which us free and open to the public--will take place this Sunday, April 3rd, from 3-6.

Full details follow for both this opening at the related opening later in the month at Proteus Gowanus. Hope very much to see you there!

Please join us for two artist receptions to celebrate our special two-part exhibition

NAMING THE ANIMALS
Curious Matter, April 3 to May 15, 2011
Proteus Gowanus, April 16 to July 17, 2011

Sunday, April 3, 2011
3:00 to 6:00 pm
at CURIOUS MATTER
272 Fifth Street, Jersey City, NJ
&
Saturday, April 16, 2011
7:00 to 10:00 pm
at PROTEUS GOWANUS for Paradise III
& Naming the Animals
543 Union Street, Brooklyn, NJ

THE ARTISTS

CURIOUS MATTER: Lasse Antonsen • Julia Whitney Barnes • Jill Marleah Bell • John Bell • Arthur Bruso • Travis Childers • Matthew Cox • Joanna Ebenstein • Veronica Frenning • Patti Jordan • Heather Layton • Ross Bennett Lewis • Carrie Lincourt • Eric Lindveit • Colette Male • Marianne McCarthy • Florence Alfano McEwin • Hans van Meeuwen • Raymond E. Mingst • Elizabeth Misitano • R. Wayne Parsons • Inna Razumova • Debra Regh • Andrew Cornell Robinson

PROTEUS GOWANUS: Kristi Arnold • William Brovelli • Christian Brown • Ryan Browning • Travis Childers • Clair Chinnery • Eileen Ferara • Richard Haymes • Ellie Irons • Katherine McLeod • Suzanne Norris • Melissa Stern • Jennie Suddick • Tricia Zimic

CURIOUS MATTER is an exhibition venue for contemporary visual art located in downtown Jersey City. Curious Matter exhibitions and publications evidence the pursuit to understand and articulate our individual and collective experience of the world, real or imagined. We examine fantastic notions, confounding ideas and audacious thoughts. Curious Matter strives to foster dialogue among artists at all career stages with a calendar of regular exhibitions. Our commitment extends to our audience as we endeavor to open a door to appreciating contemporary art in an atmosphere that encourages engagement and curiosity. Curious Matter is a sponsored project of Fractured Atlas, a non-profit arts service organization.
For more info: [w] curiousmatter.blogspot.com [e] curiousmatter@comcast.net [t] 201-659-5771

DRIVING FROM MANHATTAN: Take the Holland Tunnel. When you exit the tunnel turn left onto Marin Blvd. Turn right onto 6th Street, then left onto Coles Street and left onto Fifth. Street. (It’s about 5 minutes out of the Tunnel.)

PATH FROM NYC: Take the Newark/Journal Square bound PATH train from 33rd, 23rd, 14th or 9th Streets (all at 6th Ave.) or from Christopher Street or WTC. (Note: on weekends the train stops in Hoboken before continuing to Jersey City.) Get off at

GROVE STREET station. Exit and walk West on Newark Ave. When you reach Jersey Ave. make a right and continue to 5th Street. The gallery is to the left at 272 Fifth Street.

PROTEUS GOWANUS is a gallery and reading room located on the Gowanus Canal in Brooklyn, NY. A collaborative project, the gallery develops exhibits of art, artifacts and books and hosts events that revolve around a yearlong theme linking the arts to other disciplines and to the community. In adjacent spaces, seven additional projects-in-residence have grown out of thematic exhibitions and partnerships. This year’s theme is PARADISE, an exploration of the light and dark sides of spiritual ascent and sensual escape, in which we invite artists and workers in other disciplines to respond to the siren song of that which is easy to imagine but
difficult to attain.
For more info: [w] proteusgowanus.com [e] info@proteusgowanus.com [t] 718-243-1572

DRIVING FROM MANHATTAN: (There is usually easy parking on weekends.) Continue straight off Brooklyn Bridge to Atlantic Avenue, take left on Atlantic. Go four blocks to Nevins St and take a right. Follow Nevins several blocks til you come to Sackett. Park on the next block (just before Union) and go down the alley off Nevins through the large black gates, second door on the left.

SUBWAY, R or M train to Union Street in Brooklyn: Walk two long blocks on Union (towards the Gowanus Canal) to Nevins Street. 543 Union Street is the large red brick building on right. Go right on Nevins and left down alley through large black gates. Gallery is the second door on the left.

F or G train to Carroll Street: Walk one block to Union. Turn right, walk two long blocks on Union towards the Gowanus Canal, cross the bridge, take left on Nevins, go down the alley to the second door on the left.

To see much more of the work in the exhibition, you can download a digital version of their beautifully designed catalog--the hard copy of which will eventually be available for sale on Lulu--by clicking here.

Image: Joanna Ebenstein, Natural History Museum Storage Area, 2010

Armed Forces Institute of Pathology Mission Ends; Joint Pathology Center to Open

In Beyond Good and Evil, not the PlayStation or Xbox game, but rather the completely unrelated book by Friedrich Nietzsche, he writes, "Digressions, objections, delight in mockery, carefree mistrust are signs of health; everything unconditional belongs in pathology."

If true and everything unconditional does belong in pathology that at some point in time between 1862 and the end of March 2011 it probably was first described or studied, analyzed, demonstrated, photographed, archived, taught and/or catalogued with like and compared with similar and dissimilar forms of itself at the Armed Forces Institute of Pathology (AFIP) in Washington, DC.   

Readers will know that I have been following the closing of AFIP since the 2005 Base Realignment and Closure (BRAC) Commission recommended disestablishment of the AFIP.  Since the report was released in May of 2005 after multiple political wranglings the AFIP will disestablish and permanently close by mid-September this year. The Institute ceased all education programs on October 1, 2010. Additionally on Oct. 1, the AFIP stopped accepting nonfederal civilian consultation cases. This action was followed by cessation of all research on December 15, 2010.  And on March 31 what remains of their consultation mission will come to a close when the AFIP ceases accepting cases for military members and veterans. All three AFIP missions, and the DoD Tissue Repository mission, will then become the responsibility of DOD’s new Joint Pathology Center.

The AFIP will soon release a book detailing the legacy of the AFIP.  You can see portions of it in the last AFIP Letter recently published.

On April 1, the newly formed DOD Joint Pathology Center (JPC) will beginning receiving miltary and VA cases for consultation to carry on that role performed by AFIP.  The JPC will also have oversight over the vast tissue repository and add its research and educational offerings as staffing allows.  Perhaps they may one day begin to accept civilian consultations as well.

The museum that was housed in the AFIP building will also move to a new location over the next several months and plans on re-opening in the fall.  Check out their Facebook page to see when the exhibits will re-open in their new home.

Medical Office Position

Job Description:
Electronic and paper data entry
Tracking insurance company submissions
Reconciling insurance company response with charges
Reconciling balances with responsible parent
This will acquaint employee with diagnosis and procedure coding
This will acquaint employee with insurance billing terminology and accounting
General office support
Filing medical record charts
Housekeeping of Chart files
Copying and faxing materials from charts to other offices
Printing medical consult evaluations for chart, family and primary care physician; preparing material for mailing
Shredding confidential materials
Providing family with Follow up Material electronically
This acquaints employee with health care confidentiality policies, with medical record keeping and with a wide range of medical knowledge available within the confidential medical record and from Dr. McDonough-Means about integrative health care and developmental pediatrics.
Other optional duties as time and employee ability allows:
Support for research and publications
Hours: 5-8 hours/week Pay: Hourly rate to be discussed
Qualifications:
Student who is in Honors program or with similar GPA who is planning on applying for Graduate school and/or Medical school.
Preferably a student who will be in Tucson year round – now a Junior; or if a Senior then needing and committed to work during Graduate school.
Able to commit to consistent time each week with some flexibility as to which specific hours negotiable with Dr McDonough-Means – approximate total needed: 5-8 hrs/week.
References requested from Department or prior employers.
Please contact:
Sharon McDonough-Means, MD
Integrative Developmental Pediatrics
2650 North Wyatt Drive
Tucson, Arizona 85712
520-247-0405/322-3665 FAX

Salt increases heart attack and stroke risk, even if blood pressure is normal

Joel Fuhrman, M.D.

Excess dietary salt is notorious for increasing blood pressure – blood volume increases, placing more stress on blood vessel walls. This forces the heart to pump harder against the pressure, and also structural changes that harden the vessel wall (this hardening is called stenosis) occur in response to these high pressures.
About one-third of all American adults and over 50% of those over the age of 55 have hypertension, and hypertension carries significant risks. Elevated blood pressure accounts for 62% of strokes and 49% of coronary heart disease. [1] Notably, the risk for heart attack and stroke begins climbing with systolic pressures (first number in the blood pressure reading) above 115 mm Hg – considered “normal” by most standards.[2] Also, dietary salt is not only dangerous to the cardiovascular system, but also contributes to kidney disease, osteoporosis , ulcers, and stomach cancer. [3] Read more...

Cardiofy Heart Care Supplement

Tips and Tricks for Scanning and Viewing Digital Slides – Aperio Webinar April 27th

This should be a good one.  Ole Eichhorn is a good speaker who has a way of making technical issues simple and user friendly

Wednesday, April 27, 2011

7:00 am Pacific Time, 10:00 am Eastern Time 
(3:00 pm London GMT / 9:00 am Mexico City Standard Time) 

 OR

 
4:00 pm Pacific Time, 7:00 pm Eastern Time
(8:00 am Japan Time / 9:00 am Australia EST April 28)  

Presenter:
Ole Eichhorn, Chief Technology Officer, Aperio 

In this 60-minute, complimentary webinar, we will present simple tips for getting the most out of your digital pathology system, including ScanScope scanners, Spectrum Plus, the latest Spectrum Plus release, and the ImageScope and WebScope viewing tools. 

Topics include:

  • Ways to improve your scan quality
  • Mouse and keyboard shortcuts
  • Viewing navigation: panning and zooming through digital slides
  • Saving and bookmarking specific views of slides
  • Annotation tips and techniques
  • Interfacing to third-party image tools
  • A look at Spectrum Release 11

This webinar will cover many of the tips we’ve posted online at blog.aperio.com/chalk-tip-index.html. Please visit blog.aperio.com often for Pathology News and ongoing tips and techniques.

To register for the 7am PDT session, click here.https://aperio.webex.com/aperio/onstage/g.php?t=a&d=489644732
To register for the 4pm PDT session, click here. 
https://aperio.webex.com/aperio/onstage/g.php?t=a&d=481795953

You may also register by visiting the Aperio Events page.

You will receive a confirmation email upon registration with a web link that will lead you to the online event. Simply visit the link at the assigned time. The session is secure and easy to access. If you have any questions or would like additional information, please contact the Aperio Events Team at events@aperio.com or 760.539.1192.  

 

Thoughts on CAP Companion Society Meeting at USCAP 2011

A couple of weeks have passed and enough time has passed to digest what I thought about the CAP Companion Society I was fortunate enough to speak at the recent USCAP meeting.  Unfortunately, this was the only part of the meeting I was able to attend this year.  For a more complete review of the exhibits and exhibit floor check out Ole Eichorn's The Daily Scan and Amanda Lowe's DPC Blog. Both have excellent summaries of the vendors, their booths and recent updates to product offerings.

The CAP Companion Society Meeting this year was dedicated to whole slide imaging.  I think this says a lot for the College and the field in general.  Timely topics are usually chosen for this companion meeting and topics are generally those that are suggested by the membership in terms of current issues that may be of interest to the general practicing pathologist.  

The session is generally well attended by CAP members and as most of the companion meetings take place over the weekend and there are quite a few, attendees have a wide range of meetings to attend.  This particularly society meeting generally does well but this year the number seemed larger than most.

I was able to view the speaker presentations on the USCAP website without log in.

As you will see from the presentations the topics covered regulatory issues, educational applications, clinical applications, lessons learned from the speakers, business models and challenges to overcome.  

Paul Valenstein's talk on the issue of validation presented the real challenges that face the FDA to tackle the problem.  Be sure to check out his talk if this is of interest to you for a thorough review of the regulatory issues.

Liron Pantanowitz reviewed educational applications in part using Pathology 2.0 and other application models.

Andrew Evans and myself covered clinical applications with Andrew reviewing now multiple years and thousands of cases reviewed with telepathology with multiple platforms and expansion of their practice model into remote areas of Ontario.  Still one of the best examples of a successful telemedicine program with many deliverables, efficiencies and continued successes that anyone should review if you are setting up any telepathology program.

As for my talk, it was largely a review of my recent CAP meeting session on telepathology and whole slide imaging.  Fortunately, I don't think there was much redundancy among the attendees and my bad jokes were just as ineffective.  TIme for some new material, new slides and new jokes.

The session concluded with John Pfeifer and David Wilbur discussing their experiences in large, sub-specialty oriented academic practices.  John discussed issues associated with volume scanning in a large organization, the issues with large academic practices and their success with a CoPath interface.  David Wilbur discussed their projects with Corista and proposed consultation models for MGH.

At the end of the session there was a short panel Q&A and it was quickly and clearly evident from the questions asked and the follow up points made by the panelists that digital pathology is no longer a matter of "if" but "how".  

This is my problem in my lab, my hospital, my group, with my colleagues, I know we need to adopt this technology, but how?  Where do I start? And how do I validate?  I need to read cases instead of traveling to the cases.  But what about resolution? Legal issues? Image storage, bandwidth and documentation of digital rather than glass review. 

The answers will come as they have in the past from shared experience and collective lessons learned that facilitate innovation and adoption. 

 

HistoRx Receives Fundamental Patent on Standardization of Results In Digital Pathology

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE HistoRx, Inc.

HistoRx, Inc., recently announced that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for standardization of digital microscopy instruments in order to go beyond imaging to generating high-quality reproducible data that precisely relates to biomarker concentrations in tissue sections.

Digital pathology involves taking digital pictures of an anatomic pathology specimen, a slide with cells or a thinly-sliced piece of tissue, and managing the interpretation and storage of the resulting images.  While most companies involved in digital pathology emphasize generation and storage of images for interpretation, HistoRx is the only company to bring reproducibility, or standardization, to those images, to quantify protein in tissue for accurate biomarker measurement.

"This patent covers HistoRx's unique ability to ensure that multiple instruments performing the same test, whether in one or many locations, can give the same result for a patient's slide," said Jason Christiansen, Senior Director of Operations at HistoRx and the lead inventor.  "We don't make digital microscopy systems, we make digital microscopy systems better."

Quantitative IHC (qIHC) is only as good as the image from which the data is derived.  Robust quantitative data can only be achieved from reproducible images, generated with information from standardized digital microscopy instruments.  HistoRx is the first company to address standardization of digital microscopy instruments to deliver high quality reproducible data that precisely relates to biomarker concentrations in tissue sections -- data that is essential to the development and delivery of personalized cancer care.

The patented approach applies to qIHC, as well as all uses of digital microscopy and establishes the definition for standardization and reproducibility in both brightfield and fluorescent digital pathology.

U.S. Patent No. 7,907,271 is the first assigned to HistoRx and is entitled "Method and System for Standardizing Microscope Instruments."  Inventors Jason Christiansen,Robert Pinard, Maciej Zerkowski and Greg Tedeschi are all current or former employees of the company.

AQUA technology is an automated, quantitative IHC testing method that enables measurement of protein biomarkers in tissue as an aid to a pathologist's diagnosis.  Such precise determination of first, the location within the tumor cell and second, the amount in each location is not possible with any other method, digital or otherwise.  AQUA analysis is used in cancer research by twenty leading academic centers worldwide, is part of the clinical development plans for more than ten drug candidates from major pharma companies, and has been cited in more than 90 peer-reviewed publications.  The first use of AQUA technology in the clinical diagnostic setting occurred in 2010 with the launch by Genoptix Inc. (a subsidiary of Novartis) of diagnostic tests based on AQUA technology licensed from HistoRx. AQUA technology is currently available on the ScanScope FL™ from Aperio and will be available later this year on the Nuance™ and Vectra™ systems from Caliper Life Sciences.

About HistoRx, Inc.

HistoRx, Inc. is a leading developer of tissue-based diagnostic solutions to advance individualized patient care.  The company's products and services are based on proprietary analysis of tissue biomarkers using AQUA® technology.  AQUA® technology is the only platform capable of precisely measuring protein biomarker concentration with sub-cellular resolution in tissue sections, enabling fully objective, standardized, reproducible, and automated analysis to guide drug development and therapeutic decision-making.  HistoRx is commercializing a pipeline of proprietary diagnostic products targeting improved treatment decision-making and patient outcomes in cancer care.  For more information, please visit http://www.historx.com.

©2011 PR Newswire. All Rights Reserved.

 

Review of Methods in Medical Informatics by Dr. Jules Berman

I recently had a chance to look at Methods in Medical Informatics, the latest of several books by Jules Berman, PhD, MD, published last year. 

image from www.amazon.com Three computer languages satisfy the minimum requirements for biomedical programming: Perl, Python, and Ruby. These languages are: free; fast; and easy to learn. Each provides a large user community; easy environment for correcting errors; large, available library of specialized modules; built-in pattern recognition commands; and yet are capable of large-scale data-analysis for advanced programmers.

One of Dr. Berman's colleagues wrote this, "This list, enumerated by Dr. Berman and many others, should be chiseled in granite, published everywhere, and yelled from the rooftops. Greater compliance with this list would clear out much of the clutter in the chaotic world of biomedical informatics."

This book is a no-nonsense "how to" for programming in medical informatics written in a similar style to Dr. Berman's previous works on the topic with the exception that these languages are freely available and take advantage of public databases.  The book is short on history, background and significant explanation, rather Dr. Berman quickly and easily takes the reader into short scripts of code with accompanying algorithms to rapidly illustrate simplicity yet thoroughness to the program being written.  For more substantive background and discussion I suggest you look at his prior works.

The book contains 27 chapters that are parceled into 4 parts -- fundamental algorithms and methods of medical informatics; medical data resources; primary tasks of medical informatics and medical discovery. The parts and chapters allow a flow to the book that makes it both easy to pick up where you left off and hard to put down when you need to.  Despite the subject matter and largely a collection of short scripts, like any good book, there is a story and one can find themself asking "What if?" when a scenario is presented and others are built upon it to ask or answer a particular question.

A must have for any healthcare professional with informatics needs or interests.  Retails for around $50.

 

Jules J. Berman, studied mathematics at M.I.T., earned a Ph.D. in pathology and an M.D., practiced general pathology for over a decade, and served as Program Director for the Pathology Informatics program at the U. S. National Cancer Institute. He has published over one hundred first-author papers in peer-reviewed journals in this field. He brings together this varied background in a flowing no-nonsense writing style.

New Free White Paper – Tissue Contamination

Risk of Misdiagnosis Due to Tissue Contamination May be Higher for Certain Specimen Types:

Changes to Laboratory Staining Techniques Offer Opportunity to Reduce Contamination Events

FREE Special Edition White Paper

download your report now!

Download Your FREE Special Report Today!
Simply Complete the Form Below

 

Risk of Misdiagnosis Due to Tissue Contamination May be Higher for Certain Specimen Types: Changes to laboratory staining techniques offer opportunity to reduce contamination eventsTissue contamination in the anatomic pathology lab has long been accepted as a part of the working environment. While laboratories strive to reduce contamination as much as possible, it has been viewed more as an inconvenience than as a serious issue.

But that view is changing. As this white paper demonstrates, the risk of misinterpretation may be greater than most pathologists currently realize, especially in certain tissue types. Also, this paper illuminates a source of significant contamination that has largely been overlooked—staining baths.

Patient safety demands that laboratories take every precaution against misinterpretation. But even in instances where the risk of misinterpretation is unlikely, loss of productivity as a result of contamination is a serious issue.

As the author of this white paper notes, determining if an artifact on a slide is a contaminant or patient tissue can require minutes, or even hours, of extra time in analysis. With a critical shortage of pathologists, productivity is an issue that laboratories cannot ignore.  With the average age of pathologists over 50, this shortage will grow more critical as baby boomers retire.

The Dark Report is happy to offer our readers a chance to download our recently published FREE White Paper “Risk of Misdiagnosis Due to Tissue Contamination May be Higher for Certain Specimen Types: Changes to Laboratory Staining Techniques Offer Opportunity to Reduce Contamination Events” at absolutely no charge. This free download will provide readers with a detailed overview of current legal challenges that your lab may encounter in the near future.


download your report now!

Here is just some of what you will take away…

  1. The three main specimen types that are considered high-risk for misdiagnosis.
  2. The most important factors enabling a pathologist to recognize contamination.
  3. Some ways to avoid contamination during the staining process.
  4. For more about changes to laboratory staining techniques, please CLICK HERE

download your report now!


Table of Contents

Disclosure — Page 2

Preface — Page 4

Chapter 1. Background — Page 5

Chapter 2.
 Sources of Contamination of Patient Slides — Page 6

Chapter 3.
 Specimen Types With Additional Risk — Page 8

Chapter 4.
 Elevated Risks for Specialty Labs — Page 15

Chapter 5.
 Cost of Contamination — Page 16

Chapter 6.
 Protecting Against Contamination — Page 18

Chapter 7.
 Conclusion— Page 20 

References — Page 21


Appendices

A-1 About John B. Carpenter, M.D. — Page 23
A-2 About Ventana Medical Systems, Inc.— Page 24
A-3 About DARK DAILY— Page 25
A-4 About The Dark Intelligence Group, Inc., and The Dark Report— Page 26
A-5 About Executive War College on Laboratory and Pathology Management— Page 27
A-6 About Karen Branz— Page 29  


Terms of Use — Page 32

 

Race is on for iPhone-lik?e health IT apps

BOSTON – A new platform created specifically to boost healthcare IT innovation is now available to the public, kicking off a $5,000 competition that challenges developers to create Web applications for patients, physicians and public health.

Researchers at Children's Hospital Boston and Harvard Medical School created SMArt (Substitutable Medical Applications, reusable technologies) platform architecture to support a flexible health information technology environment and promote innovation. The Office of the National Coordinator for Health Information Technology awarded $15 million for the project in April 2010 through the Strategic Health IT Advanced Research Projects (SHARP) program.

[See also: Some SHARP ideas for health IT.]

First described in a March 2009 New England Journal of Medicine article the SMArt architecture is an iPhone-like health IT platform model that aims to transform the way health IT supports healthcare by facilitating the development of medical applications that are scalable and substitutable. The goal is to drive competition, innovation and increased efficiency in the functionality of technology for improved health care.

[See also: Children’s Hospital Boston at work on iPhone-like app.]

The SMArt project will enable the equivalent of an iTunes App Store for health and support applications ranging from medication managers for patients at home to e-prescribing applications and decision support for physicians in the office.

"The goal of this model is to enable a substantial shift towards technologies that are flexible and able to quickly adapt to meet the various needs of their users on a variety of devices," said Kenneth Mandl, MD, of the Children's Hospital Informatics Program and Harvard Medical School, and co-lead on the SMArt project. "As developers begin to compete on quality, value and usability, we expect to see the introduction of an array of innovative functions and a drop in the cost of healthcare technology. Just as staple applications of the iPad, Android, and Blackberry platforms constantly evolve and compete to meet user demands, the SMArt platform will enable health IT to do the same."

In August, Mandl and Isaac Kohane, MD, also with the Children’s Hospital Informatic Program and Harvard Medical School and co-lead on the SMArt project, held a SMArt developer meeting that included more than 60 representatives from academia, government and business.

Multiple prototypes of the SMArt platform were presented and feedback was collected from software developers and the health IT community. Following that meeting, the team built the SMArt platform architecture and interface that was made publicly available March 9.

"There is an enormous talent pool available in our country's developers and entrepreneurs to help drive new Web and mobile health IT solutions that support healthcare functions," said Kohane. "Through this competition we hope to excite this pool, to spark their imaginations and partner with them to move new ideas forward."
"Future developments in health IT should always be driven by empowering physicians and improving patient care," addd Wil Yu, director of the SHARP program at the Office of the National Coordinator for Health IT.

Developers interested in learning more about the SMArt project and/or participating in the SMArt health app challenge may visit http://www.smartplatforms.org/challenge/ for complete details. Entrants are eligible to receive an award – $5,000 and release in an "App Store" –  for best application. The deadline for submission is May 31, 2011 11:59PM EDT.

The judges
A panel of industry leaders has been assembled to judge the challenge and will review submitted apps and announce winners in June 2011. Judges will include Susanna Fox, director of Health Research at the Pew Internet & American Life Project; Regina Herzlinger, the Nancy R. McPherson Professor of Business Administration at the Harvard Business School; David Kibbe, senior advisor to the American Academy of Family Physicians and principal at The Kibbe Group LLC; Ben Shneiderman, professor of Computer Science at the Human-Computer Interaction Laboratory at the University of Maryland, College Park; Doug Solomon, chief technology officer at IDEO; Edward Tufte, professor emeritus of Political Science, Statistics, and Computer Science at Yale University; and Jim Walker, chief health information officer at Geisinger Health Systems.

"Blood Work: Medicine and Murder in the Scientific Revolution," Illustrated Lecture and Book Signing with Holly Tucker, Tomorrow Night at Observatory!


Tomorrow night at Observatory! Very much hope to see you there.

Blood Work: Medicine and Murder in the Scientific Revolution
Lecture and Book Signing with Professor and Author Holly Tucker
Date: Tuesday, March 22
Time: 8 PM
Admission: $5
Presented by Morbid Anatomy

In 1667 physician Jean-Baptiste Denis transfused calf’s blood into the body of Antoine Mauroy, an infamous madman known to tear through the streets of Paris naked and screaming. With this, Denis--a brash physician with a taste for the limelight--enraged both the elite doctors who wanted to perform the first animal-to-human blood transfusion themselves and powerful conservatives who believed he was toying with forces of nature that he didn’t understand. It only got worse when just days after the experiment, Mauroy was dead, and Denis was framed for murder. A trial ensued and Denis became a kind of 17th century Dr. Kevorkian, a stubborn man of science who held the public spellbound and reveled in controversy.

Animal-to-human transfusion was then on the cutting-edge of medicine. In an era in which superstition sparred with science, transfusion was also a flashpoint for controversy. Conservative camps in Catholic France, including King Louis XIV’s Academy of Sciences, railed against transfusion and predicted that before long animal-human hybrids would walk among us. Ambitious scientists fumed at being held back by retrograde forces who would choke the progress of science. A confused public feared that they would be crushed by cosmic backlash or social upheaval.

Join us tonight as Dr. Tucker tells us this fascinating story of a notorious madman, a renegade physician, a murder that remained unsolved for over three centuries, and the true story one of the world’s first blood transfusions in 17th century France as detailed in her new book, Blood Work: Medicine and Murder in the Scientific Revolution (W.W. Norton, March 2011).

Copies of Blood Work will be also available for sale and signing.

Holly Tucker is an associate professor at Vanderbilt University’s Center for Medicine, Health & Society and the Department of French & Italian. Her research focuses on the history of medicine. She writes for publications including the Wall Street Journal, San Francisco Chronicle, New Scientist, and Christian Science Monitor. She lives in Nashville, Tennessee. You can find out more at her website, http://www.holly-tucker.com and her blog http://www.wondersandmarvels.com.

You can find out more about the book by clicking here, and more about this event on the Observatory website by clicking here; you can access this event on Facebook here. You can get directions to Observatory--which is next door to the Morbid Anatomy Library (more on that here)--by clicking here. You can find out more about Observatory here, join our mailing list by clicking here, and join us on Facebook by clicking here.

Futurescape Fast Approaching – Register Now

You will want to be a part of Futurescape IV, the CAP Foundation’s conference, coming soon — April 15-17, 2011 — at the InterContinental Hotel O’Hare in Rosemont, Ill.

At Futurescape, you’ll connect the most innovative and novel areas of development with implementation in the current practice of pathology. You’ll learn how the latest technologies are defining future treatment for patients. Plus, pre-conference industry workshops are sure to provide additional excitement, as well as plenty of opportunity to meet and network with pioneering innovators in pathology.

Act now, as registration closes April 6, 2011. The CAP Travel Desk can help you with airline reservations: 1-800-323-4040 ext. 7800. And contact the InterContinental Hotel to secure the special Futurescape conference rate: 1-800-381-9552.

Registration is now available on-line —$395 for CAP Members and Laboratorians; $525 for Non-CAP Members; $125 for Pathology Residents; or print the downloadable registration form and:

  • Mail to:

    CAP Foundation
    Futurescape
    325 Waukegan Road
    Northfield, IL
    60093

  • Fax to 847-832-8749
  • Scan and email to CAPFdn@cap.org

 

Rehab Technician

Congratulations to all the soon to be graduates! For all of you who are interested in a career in Physical Therapy or Occupational Therapy I have a great opportunity for you at St. Joseph's Hospital.
I am a Rehab Technician and have recently been accepted into my first choice graduate program for Doctor of Physical Therapy. We are now looking for a full time replacement to work in the Neurological Institute.
I highly recommend this position to anyone with aspirations to be a therapist. It not only introduced me to a wealth of first hand experiences with direct patient care and undoubtedly got me into my first choice graduate school, but I can honestly say I cannot imagine a better group of people to work with. When I become a therapist I will certainly be returning to work with this exceptional group of people and extraordinary manager, Kary Spradling.
If you are interested in applying for the position you can contact Kary Spradling, the Inpatient Rehab Therapy Manager, at (520) 873-5070 and leave a message. You can also e-mail her at
kspradling@carondelet.org and put Rehab Technician in the subject bar. I recommend starting the process before graduation.

Changes to Laboratory Staining Techniques Offer Opportunity to Reduce Contamination Events

Tissue contamination in the anatomic pathology lab has long been accepted as a part of the working environment. While laboratories strive to reduce contamination as much as possible, it has been viewed more as an inconvenience than as a serious issue.

But that view is changing. As this white paper demonstrates, the risk of misinterpretation may be greater than most pathologists currently realize, especially in certain tissue types. Also, this paper illuminates a source of significant contamination that has largely been overlooked—staining baths.

Patient safety demands that laboratories take every precaution against misinterpretation. But even in instances where the risk of misinterpretation is unlikely, loss of productivity as a result of contamination is a serious issue.

As the author of this white paper notes, determining if an artifact on a slide is a contaminant or patient tissue can require minutes, or even hours, of extra time in analysis. With a critical shortage of pathologists, productivity is an issue that laboratories cannot ignore.  With the average age of pathologists over 50, this shortage will grow more critical as baby boomers retire.

The Dark Report is happy to offer our readers a chance to download our recently published FREE White Paper “Risk of Misdiagnosis Due to Tissue Contamination May be Higher for Certain Specimen Types: Changes to Laboratory Staining Techniques Offer Opportunity to Reduce Contamination Events” at absolutely no charge. This free download will provide readers with a detailed overview of current legal challenges that your lab may encounter in the near future.

Here is just some of what you will take away…

  1. The three main specimen types that are considered high-risk for misdiagnosis.
  2. The most important factors enabling a pathologist to recognize contamination.
  3. Some ways to avoid contamination during the staining process.
  4. For more about changes to laboratory staining techniques, please CLICK HERE

Table of Contents

Disclosure — Page 2

Preface — Page 4

Chapter 1. Background — Page 5

Chapter 2.
Sources of Contamination of Patient Slides — Page 6

Chapter 3.
Specimen Types With Additional Risk — Page 8

Chapter 4.
Elevated Risks for Specialty Labs — Page 15

Chapter 5.
Cost of Contamination — Page 16

Chapter 6.
Protecting Against Contamination — Page 18

Chapter 7.
Conclusion— Page 20

References — Page 21

Appendices

A-1 About John B. Carpenter, M.D. — Page 23
A-2 About Ventana Medical Systems, Inc.— Page 24
A-3 About DARK DAILY— Page 25
A-4 About The Dark Intelligence Group, Inc., and The Dark Report— Page 26
A-5 About Executive War College on Laboratory and Pathology Management— Page 27
A-6 About Karen Branz— Page 29

Terms of Use — Page 32


download your report now!

Aurora Interactive and Galderma to Develop the World Leading Digital Dermatology Research Tool

MONTREAL, CANADA--Aurora Interactive, a world leader in digital pathology communications, announced Thursday the company has signed a partnership contract with Galderma, a global leading pharmaceutical company specializing in the research, development and marketing of innovative medical solutions in dermatology.

The partnership contract is aimed at developing its mScope communication platform and viewer for dermatology research & development at Galderma's R&D center at Sophia Antipolis, France. Galderma forms licensing partnerships around innovative product candidates and technologies.

"The partnership between Aurora and Galderma will allow the adaptation of the best digital technology suite to achieve both companies ambitious goals," said Pierre Le Fèvre, president and chief executive officer for Aurora Interactive. "We are extremely proud to be associated with furthering dermatology research. The decision to facilitate collaboration between researchers is consistent with our company's collaborative Web 2.0 philosophy and mScope product" he added.

The 19,300-sq. meter state-of-the-art R&D center at Sophia Antipolis is Galderma's largest facility and positions the company as the world's leading investor in dermatology R&D. To drive sustained growth, Galderma invests approximately 20 percent of its revenues to discover and develop new drugs and access innovative technologies

About Aurora Interactive Ltd.

Aurora Interactive has developedthe leadingweb-based software platform (mScope) for simplification, productivity, and ease of communications.mScope's Universal Web Viewer has collaborative tools to view medical slides and images anytime, anywhere, regardless of file format.The software has three applications to aid digital pathology web-based communications: mScope Education, mScope Clinical, and mScope Universal Viewer. Aurora's mission is to improve patient outcomes and help members of the medical community achieve their full potential by eliminating the learning, diagnostic, and collaborative restrictions imposed by time and space. http://www.aurorainteractive.com

About Galderma

Founded in 1981, Galderma is a joint venture between Nestlé and L'Oréal and today employs more than 3,000 people. The company, headed by President & CEO Humberto C. Antunes, has wholly-owned affiliates in 31 countries and a worldwide network of exclusive sales agents. In 2009, sales reached 978 million Euros, an increase of 10.8%* over 2008. Committed to the future of dermatology, Galderma's ambition is to be recognized as the most competent and successful innovation-based company focused exclusively on meeting the needs of dermatology patients and physicians. http://www.galderma.com